JR

Jalakantapuram Ramaswamy Krishnamoorthy

Director Managing Director DIN 00773435
DIN 00773435 First appointment Apr 1990 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Apr 1990
Shareholding value β€’β€’β€’β€’ Premium profile

About Jalakantapuram Ramaswamy Krishnamoorthy

Data last updated:

Jalakantapuram Ramaswamy Krishnamoorthy was a Managing Director at Dr.Jrk's Research And Pharmaceuticals Private Limited (1990–2021). The company operates in Pharma.

DIN 00773435
Primary Designation Managing Director
Industry Pharma
First Appointment 01 Apr 1990

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director01 Apr 19901990₹19.15 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dr.Jrk's Research And Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jalakantapuram Ramaswamy Krishnamoorthy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jalakantapuram Ramaswamy Krishnamoorthy

Jalakantapuram Ramaswamy Krishnamoorthy was first appointed on 01 Apr 1990 as Managing Director at Dr.Jrk's Research And Pharmaceuticals Private Limited.

Jalakantapuram Ramaswamy Krishnamoorthy held 1 earlier board appointment: Dr.Jrk's Research And Pharmaceuticals Private Limited (Managing Director, 01 Apr 1990 to 27 Jan 2021).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available